Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers

Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology

Sept. 14, 2018 | By Jill Christensen / Fred Hutch News Service

Three Fred Hutch researchers recently were awarded a total of $1.5 million from the Andy Hill Cancer Research Endowment, a public-private partnership that supports cancer research in Washington.

View story >


Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research

Pediatric cancer physician-scientist feted at rooftop reception

Aug. 30, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutch pediatric leukemia specialist Dr. Marie Bleakley has been named the Gerdin Family Endowed Chair for Leukemia Research, which was funded by the generosity of a patient family from Iowa.

View story >


Want to make better T-cell therapies? First, figure out how they work.

New study maps out activities, effects of widely used components in cellular immunotherapies

Aug. 21, 2018 | By Susan Keown / Fred Hutch News Service

This work "gives us a direction" to create better, next-gen versions of this type of cancer immunotherapy, called CAR T-cell therapy, the researchers said.

View story >


Dr. Geoffrey Hill 3rd recipient of José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research

Endowments provide faculty with freedom and flexibility to pursue critical research endeavors

Aug. 14, 2018 | By Kristen Woodward / Fred Hutch News Service

Hematologist Dr. Geoffrey Hill, a physician-scientist who was recently recruited from Australia to lead Hematopoietic Stem Cell Transplantation at Fred Hutch, is the third and most recent recipient of the José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research.

View story >


Dr. Yingqi Zhao receives SWOG Coltman Fellowship early-career award

She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials

Aug. 8, 2018 | By Colin Petersdorf / Fred Hutch News Service

Fred Hutchinson Cancer Research Center biostatistician Dr. Yingqi Zhao has been awarded the Dr. Charles A. Coltman Jr. Fellowship, which recognizes and funds prolific early- and mid-career scientists from affiliated institutions within SWOG, a national clinical trials network.

View story >


Improving cancer vaccines with T-cell programming nanoparticles

Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology

July 31, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutch immunobioengineer Dr. Matthias Stephan has received an award to support the development of a combined T-cell programming, cancer-vaccine strategy to treat cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.